Baxter Hlthcare Company Profile

✉ Email this page to a colleague

BAXTER HLTHCARE has two hundred and twenty-four approved drugs.

There are thirty-one US patents protecting BAXTER HLTHCARE drugs. There are three tentative approvals on BAXTER HLTHCARE drugs.

There are seventy-two patent family members on BAXTER HLTHCARE drugs in twenty countries and three hundred and forty supplementary protection certificates in seventeen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Baxter Hlthcare Corp	TOBRAMYCIN SULFATE	tobramycin sulfate	INJECTABLE;INJECTION	206965-001	Jul 1, 2016	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	LACTATED RINGER'S IN PLASTIC CONTAINER	calcium chloride; potassium chloride; sodium chloride; sodium lactate	SOLUTION;IRRIGATION	018921-001	Apr 3, 1984	AT	RX	Yes	Yes		⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare Corp	FOSAPREPITANT DIMEGLUMINE	fosaprepitant dimeglumine	POWDER;INTRAVENOUS	211860-001	Sep 5, 2019		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Baxter Hlthcare	ANCEF IN PLASTIC CONTAINER	cefazolin sodium	INJECTABLE;INJECTION	063002-002	Mar 28, 1991		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Baxter Hlthcare Corp	ZOSYN IN PLASTIC CONTAINER	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	050750-003	Feb 24, 1998	7,915,229	⤷ Start Trial
Baxter Hlthcare	CYTOXAN (LYOPHILIZED)	cyclophosphamide	INJECTABLE;INJECTION	012142-008	Jan 4, 1984	4,537,883	⤷ Start Trial
Baxter Hlthcare Corp	PROTOPAM CHLORIDE	pralidoxime chloride	INJECTABLE;INJECTION	018799-001	Dec 13, 1982	3,629,425	⤷ Start Trial
Baxter Hlthcare	MESNEX	mesna	INJECTABLE;INTRAVENOUS	019884-001	Dec 30, 1988	4,220,660	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	10 mg/mL, 250 mL infusion bags and 20 mg/mL, 100 mL infusion bags	➤ Subscribe	2014-01-31
➤ Subscribe	Inhalation	99.90%	➤ Subscribe	2008-09-11

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1273292	C01273292/01	Switzerland	⤷ Start Trial	PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009
2932970	1890039-9	Sweden	⤷ Start Trial	PRODUCT NAME: DOLUTEGRAVIR SODIUM + RILPIVIRINE HYDROCHLORIDE; REG. NO/DATE: EU/1/18/1282 20180518
2365988	PA2018004	Lithuania	⤷ Start Trial	PRODUCT NAME: PATIROMERO, SORBITOLIO IR KALCIO KOMPLEKSAS IR JO DRUSKOS; REGISTRATION NO/DATE: EU/1/17/1179 20170719
1532149	CA 2013 00001	Denmark	⤷ Start Trial	PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3,7-DIHYDROPURIN-2,6-DION ENANTIOMERER OG SALTE DERAF - SAERLIGT LINAGLIPTIN - I KOMBINATION MED METFORMINHYDROCHLORID; REG. NO/DATE: EU/1/12/780/001-028 20120720
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.